INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS

• 4 Ways To Safeguard Your Supply Of Fetal Bovine Serum

  A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain.

• Computer Systems Validation Pitfalls, Part 1: Methodology Violations

  When computer systems validation work is not performed according to protocol instructions — by cutting corners on quality outputs with the focus on profit as the main driver — this can result in drug and device companies losing profits and efficiencies.

• CLD Inefficiencies And Streamlining The Clone Selection Process

  Learn about a powerful solution that leverages cutting-edge imaging technology to provide robust evidence of clonality, precise confluence quantitation, and rapid viable cell density assays.

• How Elixirgen Manufactures Hematopoietic Stem Cells At The Bedside

  The company uses a mobile manufacturing system to produce autologous stem cell therapy for patients with dyskeratosis congenita and other telomere biology disorders.

• The Latest Strategies For Quantifying AAV Capsid Titer

  Let's take a look at the most commonly used methodologies, including established and emerging techniques, and evaluate the pros and cons of each.

• Sterility Assurance: The Fundamentals

  Sterility assurance is a critical aspect of the production of drugs and medical devices. This article covers the fundamentals, including the key components of an effective sterility assurance program.

• A Closed And Automated Cell Therapy Manufacturing Solution

  Watch to explore the inner workings of a closed and automated solution that secures and standardizes cell activation, transduction, and expansion.

• Universal Application Of The Sefia™ Expansion System

  Watch to explore the functionality of a closed and automated solution that ensures the security and standardization of your cell therapy manufacturing process.

• There's No Substitute For Deep Analytical Experience

  By focusing on precision and quality, we aim to ensure that every therapeutic product meets the highest safety benchmarks, ultimately contributing to more successful treatments for patients in need.

• Analytical Comparability Of Five Alternative AAV9 Downstream Processes

  Explore how two-column AAV processes can enhance yield and potency while maintaining high-quality standards in the production of gene therapy products.